Company / R&D per Share
Liquidia Corp R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.46
FY2025
5-year range
$0.37 / $0.70
FY2021-FY2025
Trend
-33.5%
vs FY2024
Sector context
#178 of 207
Health Care
What the data says
Liquidia Corp's r&d per share of $0.46 is lower than 86% of companies in the Health Care sector (FY2025). Declined from $0.67 to $0.46 over the past 2 years.
Based on SEC 10-K filings.
0.46 in FY2025 with a 5-year CAGR of -16.5%.
Declined from $0.67 to $0.46 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +7.7%
- 5-Year CAGR
- -16.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 207This company $0.46 Sector average $12.26
▼
-96.2% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 33.5% year-over-year.
- Ranks #178 out of 207 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.26 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.46 | -33.5% |
| FY2024 | $0.70 | +4.0% |
| FY2023 | $0.67 | +80.3% |
| FY2022 | $0.37 | -21.5% |
| FY2021 | $0.47 | -58.5% |
| FY2020 | $1.14 | -47.9% |
| FY2019 | $2.19 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026